Abivax (ABVX) Stock Price, Quote, News & History | Benzinga

Abivax SA (ABVX) Stock Price, Quote, News & History

ABVXNASDAQ

Trade with Public

Trade with Public

$98.26

1.711.77%

At close: Jun 15, 5:00 PM EST

$98.04

-0.22-0.23%

After Hours: 7:46 PM EST

OverviewNews Earnings Events Options Analyst Ratings Short Interest Stock Report

Key Statistics

Open

$99.60

Close

$98.26

Volume / Avg.

2.12M / 1.58M

Day Range

$95.70 - $103.93

52 Wk Range

5.69 - 148.83

Market Cap

$7.82B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

43

Short Interest

3.88%

Days to Cover

2.52

Recent Abivax SA News

What's Going On With Abivax Stock On Thursday?

Abivax's Phase 3 ulcerative colitis data met remission goals, but cancer cases in the study raised safety questions and analyst caution.

Vandana Singh

Why Is Abivax Stock Sinking Tuesday?

Abivax shares plunge more than 35% as cancer cases reported in a Phase 3 trial overshadow strong efficacy results for ulcerative colitis drug.

Vandana Singh

Eli Lilly Expands Into Sleep Medicine With Centessa Buyout

Eli Lilly to acquire Centessa Pharmaceuticals for $6.3B. CNTA stock surges 45% as Lilly expands its neuroscience and sleep medicine pipeline.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-178.37M

Investing Cash Flow (TTM)

-8.78M

Financing Cash Flow (TTM)

555.22M

Free Cash Flow (TTM)

-178.52M

Capital Expenditure (TTM)

-152.00K

Net Change in Cash (TTM)

372.80M

Analyst Trends and Forecast

2

Jan

1

1

Feb

2

Mar

0

0

0

0

May

3

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$7.29B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

15.54

Earnings Yield % (TTM)

-5.51%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$6.21

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

$23.00K

LT Debt Repayment (TTM)

-$53.82M

Total Cash

$477.42M

Debt to Equity

0.00

Issuance of Debt (TTM)

-$53.80M

Repayment of Debt (TTM)

-$53.82M

Key Statistics

Open

$99.60

Close

$98.26

Volume / Avg.

2.12M / 1.58M

Day Range

$95.70 - $103.93

52 Wk Range

5.69 - 148.83

Market Cap

$7.82B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

43

Short Interest

3.88%

Days to Cover

2.52

About

Sector

Health Care

Industry

Biotechnology

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Abivax (ABVX) stock?

A

You can purchase shares of Abivax (NASDAQ:ABVX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Abivax (ABVX) competitors?

A

There are no as such competitors for Abivax.

Q

What is the forecast, or price target, for Abivax (ABVX) stock?

A

Abivax has a consensus price target of $101.55.

Q

What is the current price for Abivax (ABVX)?

A

The stock price for Abivax (NASDAQ: ABVX) is $98.038 last updated June 15, 2026 at 7:46 PM EDT.

Q

Does Abivax (ABVX) pay a dividend?

A

There are no upcoming dividends for Abivax.

Q

When is Abivax (NASDAQ:ABVX) reporting earnings?

A

Abivax does not have any upcoming earnings scheduled.

Q

Is Abivax (ABVX) going to split?

A

There is no upcoming split for Abivax.

Q

What sector and industry does Abivax (ABVX) operate in?

A

Abivax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.